191 Documents disponibles chez cet éditeur
This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. Compiled over several years, it is[...]
Therapeutic communities first developed in the 1960s and have continuing relevance in the world of drug treatment today. This report presents how therapeutic communities have developed over time, with reference to seven European countries, and p[...]![THF-F. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_80449.webp?v=1776273191)
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (THF-F), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In March 20[...]
2010
RapportFRANÇAIS : Selon l'OEDT, « les problèmes liés à l'usage de drogue ne connaissent pas de limite d'âge ». Dans cette investigation spécifique publiée en même temps que son rapport annuel 2010, l'agence sur les drogues révèle pourquoi l'usage de d[...]
OEDT = EMCDDA ; L. MONTANARI ; B. GUARITA ; A. NOOR ; L. WIESSING ; F. GOMES ; D. HEDRICH ; A. PIRONA ; R. SIMON ; J. VICENTE | 2012
RapportFRANÇAIS : L'indicateur de demande de traitement, ou TDI (Treatment Demand Indicator), a été établi en 2000 à partir des travaux du groupe de coopération du Conseil de l'Europe pour la lutte contre l'abus et le trafic de drogues (Groupe Pompido[...]
OEDT = EMCDDA ; J. SCHETTINO ; F. LEUSCHNER ; L. KASTEN ; P. TOSSMANN ; E. HOCH ; M. FERRI ; B. GUARITA ; R. SIMON | 2015
RapportThis publication reviews the interventions used in the treatment of cannabis disorders and maps out the geography of cannabis treatment in Europe.
2010
RapportFRANÇAIS : Cette « Question spécifique » se penche sur la situation actuelle en matière d’usage de drogues par voie intraveineuse en Europe. Globalement, deux questions servent de fil conducteur au présent rapport : Quelles sont la prévale[...]
OEDT = EMCDDA ; J. MOUNTENEY ; E. ATKIN ; M. RUIZ ; A. BO ; J. MATIAS ; I. JEKABSONE ; L. VANDAM ; A. PIRONA | 2018
RapportThis publication is a user-friendly guide, taking the reader, step by step, through the trendspotter methodology developed by the EMCDDA to explore emerging drug trends, new patterns of use, developing drug markets and technologies. The trendspo[...]
This paper analyses how drug production in Afghanistan has evolved under the current Taliban drug ban, with a particular focus on heroin and methamphetamine. Using satellite imagery, economic data, and other indicators, it documents shifts in th[...]
A collection of narratives from substance users in Europe about their attempts to control or reduce their consumption is released today by the EMCDDA. Entitled "Users' voices", the paper illustrates how qualitative research can provide glimpses [...]
This paper describes open-source information monitoring and how we use it at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in the area of drug markets - what it is and, importantly, what it is not; the methodology for its [...]
Historique
